Zusammenfassung
In der medizinischen Praxis sind epidemiologische Wissensformen Entscheidungsgrundlage. Inzwischen hat sich auch die Idee der gemeinsamen Entscheidungsfindung durchgesetzt. Anhand zweier Fallbeispiele aus den Bereichen Brustkrebsrisiko und Brustkrebs beschreibt der Artikel, wie medizinisch-epidemiologische Informationen im Austausch zwischen Arzt und Patient für Handlungsentscheidungen berücksichtigt werden.
Die medizinischen Informationen, die in den Arzt-Patienten-Gesprächen vermittelt wurden, stellten den Entscheidungsrahmen dar und determinierten den Zeitpunkt, wann die Entscheidung getroffen wurde/werden musste. Die Patientinnen nutzten ihre Erfahrungen und Erlebnisse, um medizinischen Informationen für ihren Lebenskontext aufzugreifen und zu verstehen. Sie setzten persönliche Erfahrungen und Erfahrungen des sozialen Umfelds in Beziehung zu den ärztlich vermittelten Informationen, um eingebettet in den eigenen Lebenskontext eine Entscheidung zu treffen. Medizinische Informationen stellen außerdem ein wichtiges Mittel für das emotionale Management im Umgang mit Erkrankung dar und dienen der Versicherung des eigenen Weges. Sie eröffnen Entscheidungsräume, in denen die eigenen und die Erfahrungen anderer sowie kulturelle Vorstellungen und das soziale Netzwerk handlungsleitend sind. Es sind soziale Erfahrungen, über die die statistischen Informationen individualisiert werden und handlungsleitend werden können. Solche Prozesse können durch eine phänomenologisch geprägte Patientenorientierung, durch eine stärkere Berücksichtigung der sozialen Erfahrungen und ein Anerkennen der Patientin als zwar vulnerables, aber sehr wohl handelndes und wissendes Subjekt gestärkt werden.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
Notes
- 1.
Um den Anforderungen einer geschlechtergerechten Sprache nachzukommen und gleichzeitig die Lesbarkeit des Textes zu gewährleisten, werden in diesem Artikel die feminine und maskuline Form abwechselnd verwendet.
Literatur
Allmark, P., und A. Tod. 2006. How should public health professionals engage with lay epidemiology? Journal of Medical Ethics 32 (8): 460–463.
American Cancer Society. 2020. Cancer Facts & Figures 2020. Atlanta: American Cancer Society. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Zugegriffen am 11.11.2021.
Asad, T. 2002. Ethnographic Representation, Statistics, and Modern Power. In From the Margins: Historical Anthropology and Its Futures, Hrsg. B. K. Axel, 66–91. Durham: Duke University Press.
Beck, U., A. Giddens, und S. Lash. 2014. Reflexive Modernisierung. Eine Kontroverse. 6. Aufl. Frankfurt am Main: Suhrkamp.
Bertz, J., S. Dahm, J. Haberland, K. Kraywinkel, B.-M. Kurth, und U. Wolf. 2010. Verbreitung von Krebserkrankungen in Deutschland. Entwicklung der Prävalenzen zwischen 1990 und 2010. Beiträge zur Gesundheitsberichterstattung des Bundes. Berlin: Robert Koch-Institut. https://www.rki.de/DE/Content/Gesundheitsmonitoring/Gesundheitsberichterstattung/GBEDownloadsB/Krebspraevalenz.pdf?__blob=publicationFile. Zugegriffen am 11.11.2021
Blakeslee, S. B., W. McCaskill-Stevens, P. A. Parker, C. M. Gunn, H. Bandos, T. B. Bevers, T. A. Battaglia, A. Fagerlin, J. Müller-Nordhorn, und C. Holmberg. 2017. Deciding on breast cancer risk reduction: The role of counseling in individual decision-making – A qualitative study. Patient Education and Counseling 100 (12): 2346–2354.
Blödt, S., M. Kaiser, Y. Adam, S. Adami, M. Schultze, J. Müller-Nordhorn, und C. Holmberg. 2018. Understanding the role of health information in patients' experiences: secondary analysis of qualitative narrative interviews with people diagnosed with cancer in Germany. British Medical Journal Open 8 (3): e019576. doi: https://doi.org/10.1136/bmjopen-2017-019576.
Brick, C., M. McDowell, und A. L. J. Freeman. 2020. Risk communication in tables versus text: a registered report randomized trial on 'fact boxes'. Royal Society Open Science 7 (3): 190876. doi: https://doi.org/10.1098/rsos.190876.
Brunsson, N., und B. Jacobsson. 2005. A world of standards. Oxford: Oxford University Press.
Charles, C., A. Gafni, und T. Whelan. 1997. Shared decision-making in the medical encounter: What does it mean? (or it takes at least two to tango). Social Science & Medicine 44 (5): 681–692.
Claridge, J. A., und T. C. Fabian. 2005. History and development of evidence-based medicine. World Journal of Surgery 29 (5): 547–553.
Conroy, R. 2003. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. European Heart Journal 24 (11): 987–1003.
Cuzick, J., J. F. Forbes, I. Sestak, S. Cawthorn, H. Hamed, K. Holli, und A. Howell. 2007. Long-term results of tamoxifen prophylaxis for breast cancer – 96-month follow-up of the randomized IBIS-I trial. Journal of the National Cancer Institute 99 (4): 272–282.
Cuzick, J., I. Sestak, J. F. Forbes, M. Dowsett, J. Knox, S. Cawthorn, C. Saunders, N. Roche, R. E. Mansel, G. von Minckwitz, B. Bonanni, T. Palva, und A. Howell. 2014. Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial. The Lancet 383 (9922): 1041–1048.
Davison, C., G. D. Smith, und S. Frankel. 1991. Lay epidemiology and the prevention paradox: the implications of coronary candidacy for health education. Sociology of Health & Illness 13 (1): 1–19.
Donner-Banzhoff, N., H. Keller, E. M. Sadowski, T. Krones, E. Baum, A. Sönnichsen, und U. Popert. 2007. Individualisierte Risikoprognose für die Herz-Kreislauf-Prävention: ein Werkstattbericht. In Lehrbuch evidenzbasierte Medizin in Klinik und Praxis, Hrsg. R. Kunz, G. Ollenschläger, H. Raspe, G. Jonitz, und N. Donner-Banzhoff, 295–304. Köln: Deutscher Ärzteverlag.
Elwyn, G., A. Lloyd, C. May, T. van der Weijden, A. Stiggelbout, A. Edwards, D. L. Frosch, T. Rapley, P. Barr, T. Walsh, S. W. Grande, V. Montori, und R. Epstein. 2014. Collaborative deliberation: a model for patient care. Patient Education and Counseling 97 (2): 158–164.
Epstein, R. M., und R. E. Gramling. 2013. What is shared in shared decision making? Complex decisions when the evidence is unclear. Medical Care Research and Review 70 (1): 94–112.
Fagerlin, A., B. J. Zikmund-Fisher, P. A. Ubel, A. Jankovic, H. A. Derry, und D. M. Smith. 2007. Measuring numeracy without a math test: development of the Subjective Numeracy Scale. Medical Decision Making: An International Journal of the Society for Medical Decision Making 27 (5): 672–680.
Fagerlin, A., B. J. Zikmund-Fisher, und P. A. Ubel. 2011. Helping patients decide: ten steps to better risk communication. Journal of the National Cancer Institute 103 (19): 1436–1443.
Fisher, B., J. P. Costantino, D. L. Wickerham, C. K. Redmond, M. Kavanah, W. M. Cronin, V. Vogel, A. Robidoux, N. Dimitrov, J. Atkins, M. Daly, S. Wieand, E. Tan-Chiu, L. Ford, und N. Wolmark. 1998. Tamoxifen for prevention of breast cancer: report of the National Surgical Adjuvant Breast and Bowel Project P-1 Study. Journal of the National Cancer Institute 90 (18): 1371–1388.
Fisher, B., J. P. Costantino, D. L. Wickerham, R. S. Cecchini, W. M. Cronin, A. Robidoux, T. B. Bevers, M. T. Kavanah, J. N. Atkins, R. G. Margolese, C. D. Runowicz, J. M. James, L. G. Ford, und N. Wolmark. 2005. Tamoxifen for the prevention of breast cancer: current status of the National Surgical Adjuvant Breast and Bowel Project P-1 study. Journal of the National Cancer Institute 97 (22): 1652–1662.
Flach, J. M., M. A. Feufel, P. L. Reynolds, S. H. Parker, und K. M. Kellogg. 2017. Decisionmaking in practice: The dynamics of muddling through. Applied Ergonomics 63: 133–141.
Fosket, J. 2004. Constructing „High Risk Women“: The Development and Standardization of a Breast Cancer Risk Assessment Tool. Science, Technology, & Human Values 29 (3): 291–313.
Freedman, A. N., D. Seminara, M. H. Gail, P. Hartge, G. A. Colditz, R. Ballard-Barbash, und R. M. Pfeiffer. 2005. Cancer risk prediction models: a workshop on development, evaluation, and application. Journal of the National Cancer Institute 97 (10): 715–723.
Gadamer, H.-G. 1996. The Enigma of Health. The Art of Healing in a Scientific Age. 1. Aufl. New York: John Wiley & Sons.
Gail, M. H., und J. P. Costantino. 2001. Validating and improving models for projecting the absolute risk of breast cancer. Journal of the National Cancer Institute 93 (5): 334–335.
Gail, M. H., L. A. Brinton, D. P. Byar, D. K. Corle, S. B. Green, C. Schairer, und J. J. Mulvihill. 1989. Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. Journal of the National Cancer Institute 81 (24): 1879–1886.
Gail, M. H., J. P. Costantino, J. Bryant, R. Croyle, L. Freedman, K. Helzlsouer, und V. Vogel. 1999. Weighing the risks and benefits of tamoxifen treatment for preventing breast cancer. Journal of the National Cancer Institute 91 (21): 1829–1846.
Gail, M. H., J. P. Costantino, D. Pee, M. Bondy, L. Newman, M. Selvan, G. L. Anderson, K. E. Malone, P. A. Marchbanks, W. McCaskill-Stevens, S. A. Norman, M. S. Simon, R. Spirtas, G. Ursin, und L. Bernstein. 2007. Projecting individualized absolute invasive breast cancer risk in African American women. Journal of the National Cancer Institute 99 (23): 1782–1792.
Gigerenzer, G. 2002. Calculated risks. How to know when numbers deceive you. New York: Simon & Schuster.
Gunn, C. M., B. Bokhour, V. A. Parker, P. A. Parker, S. Blakeslee, H. Bandos, und C. Holmberg. 2019a. Exploring Explanatory Models of Risk in Breast Cancer Risk Counseling Discussions: NSABP/NRG Oncology Decision-Making Project 1. Cancer Nursing 42 (1): 3–11.
Gunn, C. M., B. G. Bokhour, V. A. Parker, T. A. Battaglia, P. A. Parker, A. Fagerlin, W. McCaskill-Stevens, H. Bandos, S. B. Blakeslee, und C. Holmberg. 2019b. Understanding Decision Making about Breast Cancer Prevention in Action: The Intersection of Perceived Risk, Perceived Control, and Social Context: NRG Oncology/NSABP DMP-1. Medical decision making: an international journal of the Society for Medical Decision Making 39 (3): 217–227.
Hacking, I. 2009. The taming of chance. Ideas in context, Bd. 17, 12. Aufl. Cambridge: Cambridge University Press.
Hanemaayer, A. 2020. Impossible Clinic. A critical sociology of evidence-based medicine. Vancouver, Canada: University of British Columbia.
Hess, V. 2000. Der wohltemperierte Mensch. Wissenschaft und Alltag des Fiebermessens (1850 – 1900). Frankfurt am Main: Campus.
Hoffmann, T. C., V. M. Montori, und C. Del Mar. 2014. The connection between evidence-based medicine and shared decision making. Journal of the American Medical Association 312 (13): 1295–1296.
Holmberg, C. 2018. What’s in a name? In Illness Narratives in Practice, Hrsg. G. Lucius-Hoene, C. Holmberg, und T. Meyer, 239–250. Oxford: Oxford University Press.
Holmberg, C., und M. Parascandola. 2010. Individualised risk estimation and the nature of prevention. Health, Risk & Society 12 (5): 441–452.
Holmberg, C., M. Daly, und W. McCaskill-Stevens. 2010. SI RLTD: Risk Scores and Decision Making: The Anatomy of a Decision to Reduce Breast Cancer Risk. Journal of Nursing and Healthcare of Chronic Illness 2 (4): 271–280.
Holmberg, C., C. Bischof, und S. Bauer. 2013. Making Predictions. Science, Technology, & Human Values 38 (3): 398–420.
Holmberg, C., E. A. Waters, K. Whitehouse, M. Daly, und W. McCaskill-Stevens. 2015a. My Lived Experiences Are More Important Than Your Probabilities: The Role of Individualized Risk Estimates for Decision Making about Participation in the Study of Tamoxifen and Raloxifene (STAR). Medical Decision Making: An International Journal of the Society for Medical Decision Making 35 (8): 1010–1022.
Holmberg, C., K. Whitehouse, M. Daly, und W. McCaskill-Stevens. 2015b. Gaining control over breast cancer risk: Transforming vulnerability, uncertainty, and the future through clinical trial participation – a qualitative study. Sociology of Health & Illness 37 (8): 1373–1387.
Holmberg, C., H. Bandos, A. Fagerlin, T. B. Bevers, T. A. Battaglia, D. L. Wickerham, und W. J. McCaskill-Stevens. 2017. NRG Oncology/National Surgical Adjuvant Breast and Bowel Project Decision-Making Project-1 Results: Decision Making in Breast Cancer Risk Reduction. Cancer Prevention Research 10 (11): 625–634.
Jerak-Zuiderent, S. 2015. Accountability from Somewhere and for Someone: Relating with Care. Science as Culture 24 (4): 412–435.
Jewson, N. D. 1976. The Disappearance of the Sick-Man from Medical Cosmology, 1770–1870. Sociology 10 (2): 225–244.
Kooperationsgemeinschaft Mammographie. o. J. Mammographie Screening Programm – Downloads. https://www.mammo-programm.de/downloads/. Zugegriffen am 11.11.2021.
Korfage, I. J., A. Fuhrel-Forbis, P. A. Ubel, B. J. Zikmund-Fisher, S. M. Greene, J. B. McClure, D. M. Smith, S. Hensley Alford, und A. Fagerlin. 2013. Informed choice about breast cancer prevention: randomized controlled trial of an online decision aid intervention. Breast Cancer Research 15 (5): R74. doi: https://doi.org/10.1186/bcr3468.
Krones, T., H. Keller, A. Sönnichsen, E.-M. Sadowski, E. Baum, K. Wegscheider, J. Rochon, und N. Donner-Banzhoff. 2008. Absolute cardiovascular disease risk and shared decision making in primary care: a randomized controlled trial. Annals of Family Medicine 6 (3): 218–227.
Lampland, M., und S. L. Star. 2009. Standards and their stories. How quantifying, classifying, and formalizing practices shape everyday life. Ithaca, NY: Cornell University Press.
Maio, G. 2017. Den kranken Menschen verstehen. Für eine Medizin der Zuwendung. 2. Aufl. Freiburg/Basel/Wien: Herder.
Marks, H. M. 2000. The progress of experiment. Science and therapeutic reform in the United States, 1900–1990. Cambridge History of Medicine. Cambridge: Cambridge University Press.
Martinez, K. A., A. Fagerlin, H. O. Witteman, C. Holmberg, und S. T. Hawley. 2016. What Matters to Women When Making Decisions About Breast Cancer Chemoprevention? The Patient 9 (2): 149–159.
Pols, J. 2014. Knowing Patients. Science, Technology, & Human Values 39 (1): 73–97.
Porter, T. M. 1996. Trust in numbers. The pursuit of objectivity in science and public life. 1. Aufl. Princeton, NJ: Princeton University Press.
Rapley, T. 2008. Distributed decision making: the anatomy of decisions-in-action. Sociology of Health & Illness 30 (3): 429–444.
Rapley, T., C. May, B. Heaven, M. Murtagh, R. Graham, E. F. S. Kaner, und R. Thomson. 2006. Doctor-patient interaction in a randomised controlled trial of decision-support tools. Social Science & Medicine 62 (9): 2267–2278.
Sackett, D. L. 1998. Evidence-based medicine. How to practice and teach EBM. 7. Aufl. New York: Churchill Livingstone.
Sackett, D. L., W. M. Rosenberg, J. A. Gray, R. B. Haynes, und W. S. Richardson. 1996. Evidence based medicine: what it is and what it isn't. British Medical Journal 312 (7023): 71–72.
Shaffer, V. A., und B. J. Zikmund-Fisher. 2018. Narratives in decision aids. In Illness Narratives in Practice, Hrsg. G. Lucius-Hoene, C. Holmberg, und T. Meyer, 251–260. Oxford: Oxford University Press.
Stiggelbout, A. M., A. H. Pieterse, und J. C. J. M. de Haes. 2015. Shared decision making: Concepts, evidence, and practice. Patient Education and Counseling 98 (10): 1172–1179.
Strathern, M. 2000. Audit cultures. Anthropological studies in accountability, ethics, and the academy (European Association of Social Anthropologists). London/New York: Routledge.
Thomsen, T. 2005. HeartScore: a new web-based approach to European cardiovascular disease risk management. European Journal of Cardiovascular Prevention and Rehabilitation: Official Journal of the European Society of Cardiology, Working Groups on Epidemiology & Prevention and Cardiac Rehabilitation and Exercise Physiology 12 (5): 424–426.
Thomsen, T. F., T. Jørgensen, H. Ibsen, und K. Borch-Johnsen. 2001. Assessment of coronary risk in general practice in relation to the use of guidelines: a survey in Denmark. Preventive Medicine 33 (4): 300–304.
Timmermanns, S., und M. Berg. 2003. The Gold Standard: The Challenge Of Evidence-Based Medicine. Philadelphia: Temple University Press.
Timmermans, S., und A. Mauck. 2005. The promises and pitfalls of evidence-based medicine. Health Affairs 24 (1): 18–28.
Vogel, V. G., J. P. Costantino, D. L. Wickerham, W. M. Cronin, und N. Wolmark. 2002. The study of tamoxifen and raloxifene: preliminary enrollment data from a randomized breast cancer risk reduction trial. Clinical Breast Cancer 3 (2): 153–159.
Vogel, V. G., J. P. Costantino, D. L. Wickerham, W. M. Cronin, R. S. Cecchini, J. N. Atkins, T. B. Bevers, L. Fehrenbacher, E. R. Pajon, J. L. Wade, A. Robidoux, R. G. Margolese, J. James, S. M. Lippman, C. D. Runowicz, P. A. Ganz, S. E. Reis, W. McCaskill-Stevens, L. G. Ford, V. C. Jordan, N. Wolmark, und National Surgical Adjuvant Breast and Bowel Project (NSABP). 2006. Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial. Journal of the American Medical Association 295 (23): 2727–2741.
Vogel, V. G., J. P. Costantino, D. L. Wickerham, W. M. Cronin, R. S. Cecchini, J. N. Atkins, T. B. Bevers, L. Fehrenbacher, E. R. Pajon, J. L. Wade, A. Robidoux, R. G. Margolese, J. James, C. D. Runowicz, P. A. Ganz, S. E. Reis, W. McCaskill-Stevens, L. G. Ford, V. C. Jordan, N. Wolmark, und National Surgical Adjuvant Breast and Bowel Project. 2010. Update of the National Surgical Adjuvant Breast and Bowel Project Study of Tamoxifen and Raloxifene (STAR) P-2 Trial: Preventing breast cancer. Cancer Prevention Research 3 (6): 696–706.
Waters, E. A., T. S. McNeel, W. McCaskill Stevens, und A. N. Freedman. 2012. Use of tamoxifen and raloxifene for breast cancer chemoprevention in 2010. Breast Cancer Research and Treatment 134 (2): 875–880.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2023 Der/die Autor(en), exklusiv lizenziert an Springer-Verlag GmbH, DE, ein Teil von Springer Nature
About this paper
Cite this paper
Holmberg, C. (2023). Epidemiologisches Wissen, persönliche Erfahrungen und Entscheidungsfindung – Überlegungen zum Konzept der Ärzte-Patienten-Beziehung. In: Baumeister, A., Schwegler, C., Woopen, C. (eds) Facetten von Gesundheitskompetenz in einer Gesellschaft der Vielfalt. Schriften zu Gesundheit und Gesellschaft - Studies on Health and Society, vol 6. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-65586-3_9
Download citation
DOI: https://doi.org/10.1007/978-3-662-65586-3_9
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-662-65585-6
Online ISBN: 978-3-662-65586-3
eBook Packages: Social Science and Law (German Language)